August 22, 2018 — The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the…Original Article
FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis
